Obstetrics & Gynecology Doctors in Shelbyville, TN Accepting Medicare

1 Obstetrics & Gynecology doctors found. Showing 1 - 1

Shelby Lynn Cunningham, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 112 Airport Business Park Dr, Suite A, Shelbyville, TN 37160 Phone: 931-685-4856    Fax: 931-685-4861

News Archive

Scripps scientists to develop new generation of broad spectrum anti-cancer therapeutics

A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.

MIT scientists are reporting new insights into how the human brain recognizes objects

MIT scientists are reporting new insights into how the human brain recognizes objects, especially faces, in work that could lead to improved machine vision systems, diagnostics for certain neurological conditions and more.

Ansaris receives milestone payment for identification of kinase-related compound for cancer, autoimmune diseases

Ansaris announced today that it has received a milestone payment for the successful identification of a kinase-related compound under its drug discovery collaboration with Ono Pharmaceutical Co., Ltd. Ono will initiate the preclinical study of the identified compound. This collaboration between Ansaris and Ono was established to focus on the discovery of kinase-related compounds for the treatment of cancer, inflammatory and autoimmune diseases.

Eating potassium-rich foods could be key to lowering blood pressure

Eating potassium-rich foods like sweet potatoes, avocados, spinach, beans, bananas -; and even coffee -; could be key to lowering blood pressure, according to Alicia McDonough, PhD, professor of cell and neurobiology at the Keck School of Medicine of the University of Southern California.

Celladon's Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

Read more Medical News

› Verified 6 days ago